Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Non-Current Assets (2021 - 2025)

Historic Non-Current Assets for Prime Medicine (PRME) over the last 5 years, with Q3 2025 value amounting to $153.6 million.

  • Prime Medicine's Non-Current Assets rose 7714.3% to $153.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $561.3 million, marking a year-over-year increase of 7530.13%. This contributed to the annual value of $85.6 million for FY2024, which is 6829.88% up from last year.
  • According to the latest figures from Q3 2025, Prime Medicine's Non-Current Assets is $153.6 million, which was up 7714.3% from $157.7 million recorded in Q2 2025.
  • Prime Medicine's 5-year Non-Current Assets high stood at $164.4 million for Q1 2025, and its period low was $31.3 million during Q4 2021.
  • Moreover, its 5-year median value for Non-Current Assets was $76.0 million (2022), whereas its average is $87.4 million.
  • Per our database at Business Quant, Prime Medicine's Non-Current Assets skyrocketed by 10365.12% in 2022 and then plummeted by 2012.84% in 2023.
  • Quarter analysis of 5 years shows Prime Medicine's Non-Current Assets stood at $31.3 million in 2021, then skyrocketed by 103.65% to $63.7 million in 2022, then fell by 20.13% to $50.9 million in 2023, then skyrocketed by 68.3% to $85.6 million in 2024, then skyrocketed by 79.4% to $153.6 million in 2025.
  • Its Non-Current Assets stands at $153.6 million for Q3 2025, versus $157.7 million for Q2 2025 and $164.4 million for Q1 2025.